Abstract
Empiric use of antibiotics such as trimethoprim-sulfamethoxazole (TMP-SMX) is very common in clinical practice with minimal adverse effects. However, some patients can experience serious side effects to this antibiotic such as Steven-Johnson syndrome and renal failure leading to increased morbidity and mortality. Rhabdomyolysis is a rare phenomenon which could occur due to various etiologies including extreme exertion, trauma, and drugs. Herein, we describe an 18-year-old immunocompetent female who developed rhabdomyolysis after use of TMP-SMX for urinary tract infections (UTI).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
